Scinvivo

Scinvivo

Optical biopsy for bladder cancer diagnostics.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*

€4.7m

Early VC
Total Funding000k
Notes (0)
More about Scinvivo
Made with AI
Edit

Scinvivo is a pioneering company in the field of medical imaging, specializing in the development of advanced in vivo imaging platforms aimed at revolutionizing cancer diagnostics. The company serves a diverse clientele, including medical professionals, payers, and patients, by providing cutting-edge Optical Coherence Tomography (OCT) imaging solutions. Operating within the healthcare and medical technology market, Scinvivo's business model focuses on the development and commercialization of high-quality imaging devices and software. The company generates revenue through the sale of its imaging platforms and associated software, as well as through grants and subsidies for innovative medical technologies. Scinvivo's flagship product, the forward-looking OCT catheter, enables medical professionals to capture detailed cross-sectional images of tissue, significantly enhancing diagnostic accuracy. The company's software, S Vision, employs advanced image processing techniques to deliver high-quality images, addressing the unmet needs of its clients. Scinvivo's team includes experts in biomedical engineering and medical imaging, contributing to the continuous improvement and innovation of its products.

Keywords: in vivo imaging, cancer diagnostics, OCT, medical technology, biomedical engineering, image processing, healthcare innovation, diagnostic accuracy, medical professionals, advanced imaging.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo